Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Differential Intrahepatic Integrated HBV DNA Patterns Between HBeAg-Positive and HBeAg-Negative Chronic Hepatitis BDaryl T-Y Lau, Elena S Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CNeal D Freedman, James E Everhart, Karen L Lindsay, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Hepatology (Baltimore, Md.)|July 28, 2006
HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trialChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2007
Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trialAnna S F Lok, James E Everhart, Raymond T Chung, et al.
Gastroenterology|October 14, 2008
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver diseaseAnna S Lok, Leonard B Seeff, Timothy R Morgan, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Differential Intrahepatic Integrated HBV DNA Patterns Between HBeAg-Positive and HBeAg-Negative Chronic Hepatitis BDaryl T-Y Lau, Elena S Kim, Zhili Wang, et al.
Hepatology (Baltimore, Md.)|June 30, 2005
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortAnna S F Lok, Marc G Ghany, Zachary D Goodman, et al.
Hepatology (Baltimore, Md.)|September 26, 2008
Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis CChihiro Morishima, Timothy R Morgan, James E Everhart, et al.
Gastroenterology|September 22, 2009
Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis CMarc G Ghany, Anna S F Lok, James E Everhart, et al.
Gastroenterology|April 2, 2004
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatmentMitchell L Shiffman, Adrian M Di Bisceglie, Karen L Lindsay, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis CNeal D Freedman, James E Everhart, Karen L Lindsay, et al.
Journal of Hepatology|September 2, 2005
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C TrialAdrian M Di Bisceglie, Richard K Sterling, Raymond T Chung, et al.
Pageof 19